• Home
  • NEW DAY MEDICINE
  • 2 (26) 2019
  • 24 -4 (26/1) 2019 — Akbarova M., Akhmedova, Suliionkulova MK, — MODERN APPROACHES TO THE TREATMENT OF BREAST CANCER PATIENTS

24 -4 (26/1) 2019 — Akbarova M., Akhmedova, Suliionkulova MK, — MODERN APPROACHES TO THE TREATMENT OF BREAST CANCER PATIENTS

MODERN APPROACHES TO THE TREATMENT OF BREAST CANCER PATIENTS

Akbarova M., Andijan State Medical Institute.

Akhmedova, Suliionkulova MK, Andijan State Medical Institute.

Urmanbaeva D.A. Andijan State Medical Institute.

Resume,

The article presents a review of the literature on the main points of the strategy for complex treatment of breast cancer (BC). The modern approach to the treatment of breast cancer is characterized by the priority of the use in clinical practice of the methods of general antitumor effects – chemotherapy and endocrinotherapy. A new concept appeared in the surgical treatment of breast cancer – organ-preserving (conservative) methods of operations, and the question of the development of recurrence of breast cancer after organ-preserving treatment, their determination and prognostic factors of occurrence was acute. In this regard, in the complex treatment of breast cancer, a large role is assigned to radiation therapy, the use of which allows performing surgical intervention in more ablastic conditions, and at this stage, it is an essential component of the complex treatment of patients after organ-preserving operations. However, private sections of the strategy for complex treatment of breast cancer are still not completely resolved.

Keywords: breast cancer, complex treatment, organ-preserving operations

First page

93

Last page

95

For citation: Akbarova M., Akhmedova. Suliionkulova MK, Urmanbaeva D.A. Modern approaches to the treatment of breast cancer patients//New Day in Medicine 2(26)2019 93-95 https://cutt.ly/FbvPPUD

List of References

  1. Нелюбина ЛА. Рак молочной железы: стратегии оценки и сни­жения риска заболевания. Вестник ТГУ. 2014;19(6):1919-27.
  2. Летягин ВП, Высоцкая ИВ, Григорьева ТА. Современные подходы к лечению больных первиино-операбельным раком молочной. Рос ОнколЖурн. 2013; 6:39-47.
  3. Семиглазов ВФ. Итоги 15-й международной конференции по раку молочной железы (Саи-Галлеи, 2017). Эскалация и деэс­калация лечения [Электронный ресурс]. Медвестаик. Портал российского врача. [дата обращения: 2018 Май 03]. https:// www.medvestnik.ru/content.
  4. Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, et al. De-escalating and escalating treatments for early- stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann. of Oncol. 2017; 28(8):1700-12. doi:10.1093/annonc/mdx308.
  5. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian T.B, et al. Long-term outcome of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011; 103(6):478-88. Doi: 10.1093/jnci/djr027.
  6. Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez- MacGregor M, Harris J.R, et al. Society of Surgical Oncology- American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on margins for breast­conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol. 2016; 6(5):287-95. Doi: 10.1016/ j.prro.2016.06.011.
  7. Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, et al. Anastrozole versus tamoxifen for the prevention of locore- gional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a doubleblind, randomised controlled trial. Lancet. 2016; 387(10021):866-73. Doi: 10.1016/S0140-6736(15)01129-0.
  8. Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast­conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014; 32:1507-15.
  9. De La Cruz L, Moody AM, Tappy EE, Blankenshi p SA, Hecht EM. Overall survival, disease-free survival, local recurrence, and nipple-areolar recurrence in the setting of nipple-sparing mastectomy: a meta-analysis and systematic review Ann Surg Oncol. 2015; 22(10):3241-49. Doi: 10.1245/s10434-015-4739-1.
  10. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whit-worth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011; 305(6):569- 75. Doi: 10.1001/jama.2011.90.
  11. Ataseven B, Lederer B, Blohmer JU, Denkert C, Gerber B, Heil J, et al. Impact of multifocal or multicentric disease on surgery and locoregion-al, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2015; 22(4): 1118-27.
  12. Santoro S, Loreti A, Cavaliere F, Costarelli L, La Pinta M, Manna E, et al. Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy. Breast. 2015; 24(5):661-66.

file

download